New at the Max Delbrück Center

Caroline Schweiger-Eisbacher is the new Scientific Advisor to the Vice President of Helmholtz Health, Maike Sander. In this role, Schweiger-Eisbacher helps facilitate collaboration and communication across the Helmholtz Health network.

Practiced in the art of bringing diverse groups of people together, Dilek Güven joins the Max Delbrück Center as our new Diversity Coordinator. “We are already diverse. I want to find ways to further our sense of togetherness,” she says.

For the next two years, Abeer Hassan will be a visiting postdoctoral fellow in Gary Lewin’s lab at Max Delbrück Center – going back and forth between Rehovot and Berlin. She seeks to learn more about the mechanisms through which mechanical forces stimulate neurons to elongate, especially after birth.

Nella Christie Delva joins the lab of Annette Hammes-Lewin’s as a Fulbright scholar. Over the next few months, she will study how environmental stressors cause genetic and neural changes in the brain during development, which can lead to mental health disorders.

The Max Delbrück Center proudly welcomes Dr. Nevine Shalaby as the new Head of the Innovation and Entrepreneurship Department. With a rich background in genetics and industry, she aims to drive research impact, foster spin-offs, and strengthen industry partnerships, aligned with the Strategy 2030.

Johannes Huppa has taken up the professorship for tumor immunology at Charité – Universitätsmedizin Berlin as of September 1. The T-cell receptor expert will also conduct research at the Max Delbrück Center in Berlin-Buch and the German Consortium for Translational Cancer Research (DKTK).

Organ-on-a-chip technologies can serve as models of human biology. But they have been limited by the inability to grow them with a vascular system. Bioengineer Professor Milica Radisic will begin a three-year fellowship at the Max Delbrück Center in Berlin-Buch to take on the challenge.

It borders on the miraculous how an entire animal emerges from a single egg cell. In order to understand the underlying molecular mechanisms, Markus Mittnenzweig is establishing the Computational and Developmental Biology Lab at the Max Delbrück Center.

Sarah Hedtrich heads a guest group at the Max Delbrück Center. The Johanna Quandt Professor at the Berlin Institute of Health at Charité (BIH) is working on organ-on-a-chip models to develop new treatment options for rare hereditary and inflammatory skin and lung diseases.

The Robson lab at the Max Delbrück Center will be studying how the 3D structure of chromatin controls genes during development and in disease. Leveraging novel single cell methods, they will look at muscular dystrophies and retinal disease. Both seem to be linked to mutations that disrupt the function of non-coding DNA.